This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: K00.51 | Special Copayment Reduction: V310 |
| B. Synonyms | — |
| C. Adult onset | Likelihood of first onset in adulthood low — in dentinogenesis imperfecta, structural dentin abnormalities are already formed during tooth development, so clinical findings are observed from the time of primary tooth eruption (from 6 months of age). First diagnosis in adulthood is rare; it is usually found in childhood or adolescence. |
| 1. History | 1882 first described by Chistiansen → 1920s clinical distinction of defective dentin formation → 1973 Shields three-type classification system → 1990s DSPP gene identified → 2001 DSPP mutations confirmed → current advances in molecular diagnosis and dental treatment. |
| 2. Causes | DSPP (dentinsialophosphoprotein) gene mutations are the main cause. DGI-II (isolated form) is due to DSPP variants. DGI-I accompanies osteogenesis imperfecta (OI) (COL1A1/COL1A2 variants). DGI-III is a rare familial form. Abnormal structure and function of dentin matrix proteins cause poor dentin mineralization. |
| 3. Genetics | DSPP gene (4q22.1): autosomal dominant. Penetrance nearly complete. DGI-II is mainly due to variants in the DSPP signal peptide and DSP domain. DGI-I is due to COL1A1/COL1A2 variants (dental phenotype of osteogenesis imperfecta). New mutations possible. |
| 4. General epidemiology | Prevalence about 1:6,000–1:8,000 (some reports 1:4,000). DGI-II is the most common of all DGI. DGI-I is present in about 50% of OI patients. No sex difference. Occurs worldwide regardless of race or region. Accurate prevalence data for Korea are limited. |
| 5. Pathophysiology | DSPP → cleavage into DSP and DPP proteins → abnormal matrix secretion by odontoblasts → poor dentin mineralization and structural abnormalities → pulp chamber obliteration and fragile dentin → enamel cracking and wear → risk of pulp exposure and infection. |
| 6. Symptoms | Tooth discoloration (amber, blue-gray, brown). Both primary and permanent teeth affected. Severe tooth wear and fracture. Pain hypersensitivity. DGI-I (with OI): accompanied by fractures, blue sclerae, and joint hypermobility. |
| 7. Signs | Teeth: opalescent or amber discoloration, cervical constriction, short roots, pulp chamber obliteration. Radiographs: bulbous crowns, pulp chamber obliteration. Dentin exposure and excessive occlusal wear after enamel cracking. |
| 8. Screening | No specific screening. Discovery of tooth discoloration or wear at routine dental checkups is the main trigger. Check family history. Assess systemic findings when OI is suspected. Early dental radiography (panoramic) is useful. |
| 9. Diagnosis | Clinical findings (tooth discoloration, wear, fracture) + radiographic findings (bulbous crowns, pulp chamber obliteration, short roots) + family history. Confirmation: DSPP gene analysis. Differentiating DGI-I: COL1A1/COL1A2 testing + systemic OI signs. Histology: abnormal dentin mineralization pattern. |
| 10. Treatment | Primary teeth: stainless steel crowns (full coverage) to prevent wear. Permanent teeth: composite resin and ceramic crowns, full crown restoration. Severe: implants or dentures. DGI-I: combined with systemic OI treatment (bisphosphonates, etc.). Regular dental follow-up essential. |
| 11. Prognosis | With active dental treatment, function can be preserved. Without treatment, severe loss of dentition. Permanent teeth are often more mildly affected than primary teeth. Systemic prognosis of DGI-I depends on OI severity. Early management of wear and pulp lesions through regular dental follow-up is important. |
| 12. Prevention | Genetic counseling and early dental care when there is a family history. Prevent unnecessary tooth wear (night mouthguard). Preimplantation genetic testing possible in familial DGI. Early restorative treatment prevents pulp exposure and infection. |
| 13. References | Shields ED, Bixler D, el-Kafrawy AM. A proposed classification for heritable human dentine defects. J Oral Pathol. 1973 … and 9 other references |
Clinical records of dentinogenesis imperfecta (DGI) began to appear in the late 19th century. In 1882, Chistiansen's description of a family with tooth discoloration and a tendency to wear was one of the early reports. In the early 20th century, many clinical cases were reported as 'defective dentin formation (dentin dysplasia or dentinogenesis imperfecta)', but disease names and classification criteria were not unified, causing confusion across the literature.
In 1973, Shields, Bixler, and el-Kafrawy proposed a system classifying DGI into three types (Type I, II, III). DGI Type I was defined as the dentin abnormality accompanying osteogenesis imperfecta (OI), Type II as the isolated form appearing only in the teeth without skeletal abnormalities, and Type III as a rare form found in a specific kindred in Maryland, USA (the Brandywine isolate). This classification is still used clinically.
Molecular biological advances came in the 1990s. Ritchie et al. performed linkage analysis narrowing the locus associated with DGI-II to the long arm of chromosome 4 (4q). In 2001, Xiao et al. and Zhang et al. independently confirmed that pathogenic variants in the DSPP (dentinsialophosphoprotein) gene cause DGI-II and some dentin dysplasia (DD), making molecular diagnosis of DGI possible for the first time.
Since then, the range of DSPP gene variants has expanded, and it has been shown that the various clinical phenotypes of DGI-II are associated with variants in different DSPP domains. For DGI-I, the association with COL1A1 and COL1A2 gene variants (the causative genes of OI) was clearly established. Today, a multidisciplinary diagnostic approach integrating clinical phenotype, radiographic findings, and genetic analysis is standard, and advances in dental technology (crowns, implants, 3D-printed prostheses) have greatly improved treatment outcomes for DGI patients.
In Korea, reports of isolated DGI cases and of cases of osteogenesis imperfecta with DGI have been made in pediatric dentistry and oral and maxillofacial surgery, and designation for the rare disease Special Copayment Reduction (V310) has strengthened treatment support.
The causes of dentinogenesis imperfecta differ by type, but they share dysfunction of proteins that play key roles in dentin matrix formation and mineralization.
DGI Type II (isolated dentinogenesis imperfecta): Caused by pathogenic variants in the DSPP (Dentinsialophosphoprotein) gene. The DSPP gene is located on the long arm of chromosome 4 (4q22.1) and encodes DSPP, the precursor protein of dentin matrix proteins. DSPP is cleaved by proteolytic enzymes into two main proteins: DSP (dentinsialoprotein) and DPP (dentin phosphoprotein, phosphophoryn). DPP plays a key role in initiating and regulating dentin mineralization, and DSP is involved in odontoblast differentiation and matrix organization. DSPP variants occur mainly in the signal peptide region, the DSP-DPP cleavage site, or the DSP domain, and abnormal DSPP protein accumulates in the endoplasmic reticulum (ER), impairing odontoblast function.
DGI Type I (with OI): Pathogenic variants in COL1A1 (17q21.33) or COL1A2 (7q21.3), the causative genes of osteogenesis imperfecta, cause structural abnormalities of type I collagen. Because type I collagen is a major matrix component not only of bone but also of dentin, dentin abnormalities accompany OI. Not all OI patients develop DGI; whether DGI is present depends on the OI type and the specific type of COL1A1/COL1A2 variant.
DGI Type III: A rare form reported mainly in a specific kindred in the Brandywine area of Maryland, USA, shown to be caused by DSPP gene variants. It has the same genetic basis as DGI-II but differs in clinical and radiographic findings.
In all three forms, odontoblasts produce abnormal dentin matrix proteins or matrix composition becomes abnormal, resulting in poor dentin mineralization and structural fragility. When the dentin is fragile, the overlying enamel loses its support, cracks, and chips off, and the exposed dentin rapidly wears and fractures.
The mode of inheritance of dentinogenesis imperfecta differs by type, but DGI-II and DGI-III are inherited as autosomal dominant, with nearly complete penetrance (about 90–100%). This means that a single copy of the pathogenic allele is sufficient for the disease to manifest. Males and females are equally affected, and children of an affected parent have a 50% chance of inheriting it.
The DSPP gene is located on the long arm of chromosome 4 (4q22.1), and of the first 11 exons, only 2 (exon 3 and exon 5) encode almost all of the DSPP protein. The DSPP gene is evolutionarily related to DMP1 (dentin matrix protein 1), located at the same locus. Pathogenic variants fall into two broad groups: ① variants in the signal peptide region or the N-terminal DSP domain (most DGI-II cases) — causing protein misfolding and endoplasmic reticulum stress (ER stress); ② variants at the DSP-DPP cleavage boundary — causing impaired separation and function of DPP.
DGI-I is caused by variants in the COL1A1 (17q21.33) or COL1A2 (7q21.3) genes, which encode the α1 and α2 chains of type I collagen. The frequency of DGI differs by OI type (OI Type I–V, etc.), and DGI is generally most frequent in OI Type III (severe). Expressivity also varies within families, so DGI severity can differ even with the same variant.
Genetic counseling must be provided when a DGI patient is diagnosed in a family. After a DSPP variant is identified, genetic testing of parents, siblings, and children is recommended. Pregnant carrier women (because it is autosomal dominant, affected women can become pregnant themselves) can consider prior counseling about the likelihood of the fetus being affected and preimplantation or prenatal genetic diagnosis.
Dentinogenesis imperfecta is a not-uncommon hereditary dental disease, with a reported worldwide prevalence of 1:6,000–1:8,000, though some studies estimate it higher at 1:4,000. Differences in incidence depend on differences in diagnostic criteria, populations, and access to diagnosis.
By type, DGI-II (isolated form) is the most common, and DGI-I (with OI) is present in about 50% of all OI patients. Considering that the worldwide prevalence of osteogenesis imperfecta is about 1:10,000–1:20,000, DGI-I may be even more numerous in absolute frequency than DGI-II. DGI-III is very rare and is reported mainly in specific regions of the United States and in consanguineous groups.
There is no difference in prevalence by sex; males and females are equally affected according to the autosomal dominant mode of inheritance. It occurs worldwide regardless of race or ethnicity, and prevalence may be high in certain regions due to a founder effect.
In Korea, accurate prevalence data are lacking, but patients are steadily found in pediatric dentistry and oral and maxillofacial surgery clinical practice. Registration for the rare disease Special Copayment Reduction (V310) can reduce the burden of dental treatment costs. When DGI-I arises during dental care of patients with osteogenesis imperfecta (OI), early dental intervention is important.
Because the mode of inheritance is autosomal dominant, it is inherited with a 50% probability from an affected parent, and multiple patients tend to occur in the same family across generations. De novo mutations are also possible, so patients without a family history can occur.
The pathogenesis of dentinogenesis imperfecta is due to abnormal production of dentin matrix proteins in odontoblasts and the resulting abnormal dentin mineralization.
Normal dentin formation: Normally, odontoblasts are arranged around the dental pulp and secrete, through each cell's process (Tomes' fiber), collagen matrix (the basis of the dentinal tubules) and non-collagenous matrix proteins such as DSP, DPP, DMP1, and MEPE. DPP (phosphophoryn) is the main mineralization-regulating protein, promoting nucleation of calcium and phosphate ions to induce hydroxyapatite crystal formation.
Mechanism of DSPP variants: Abnormal DSPP protein produced from DSPP gene variants cannot be processed normally in the endoplasmic reticulum and accumulates within it. This triggers the unfolded protein response (UPR), causing apoptosis and dysfunction of odontoblasts. As a result, the amount of secreted DPP decreases or its function becomes abnormal, hydroxyapatite crystal formation becomes irregular, and the degree of dentin mineralization becomes uneven. Abnormally formed dentin has low hardness and elasticity and is vulnerable to mechanical load.
Pulp chamber obliteration: The early pulp chamber obliteration observed radiographically in DGI results from continuous excessive deposition of abnormal dentin. Despite their dysfunction, odontoblasts continue excessive dentin deposition, so the pulp chamber narrows and eventually disappears. This pulp chamber obliteration is one of the most specific findings for the radiographic diagnosis of DGI.
Enamel cracking and tooth wear: In DGI, the enamel itself is normal or nearly normal. However, when the underlying dentin is fragile, the enamel does not receive sufficient support and cracks and chips off under mechanical stimuli such as occlusal forces. The exposed fragile dentin wears rapidly on the occlusal surface, markedly reducing tooth height.
The clinical symptoms of dentinogenesis imperfecta are mainly dental, and both primary and permanent teeth can be affected. Generally, symptoms are more severe in primary teeth, and permanent teeth are often relatively mildly affected.
Tooth discoloration: This is the most noticeable symptom. Teeth show various colors such as amber, blue-gray, and violet-brown. This is because abnormal dentin structure alters light transmission and reflection. When the color of the underlying dentin shows through the transparent enamel, the teeth may appear translucent or opalescent (opalescent dentin).
Tooth wear and fracture: Occlusal forces cause the enamel to crack and chip off, exposing the dentin beneath. The exposed dentin wears much faster than normal, and the occlusal surfaces are severely worn, reducing tooth height. In severe cases, teeth wear down to the gingival margin, markedly reducing tooth height.
Thermal and chemical hypersensitivity: When dentin is directly exposed to the oral environment after enamel loss, severe hypersensitivity to cold, hot, or sweet foods develops. This can cause pain during meals and make nutritional intake difficult.
Pulp exposure and infection: Even if the pulp chamber is obliterated after severe wear, pulp infection (pulpitis, pulp necrosis, periapical abscess) can occur when wear progresses close to the pulp or a tooth fractures. A fistula may form, causing pain and swelling.
Systemic symptoms in DGI-I: Because DGI-I accompanies osteogenesis imperfecta (OI), systemic OI symptoms such as recurrent fractures (even with minor trauma), blue sclerae, joint hypermobility, hearing loss, and scoliosis are present. Because dental findings alone cannot confirm OI, systemic evaluation is essential.
The clinical and radiographic signs of dentinogenesis imperfecta are relatively specific, and an experienced dentist or pediatric dentist can suspect it at the first visit.
Clinical findings: Generalized amber or blue-gray discoloration of primary and permanent teeth is most prominent. Enamel cracking and partial chipping are observed, and excessive occlusal wear is characteristic. The cervical region of the teeth is constricted (cervical constriction), so crowns are often bulbous. Roots are short and thin, and periapical radiolucency may be seen on X-ray.
Radiographic findings: On panoramic or bitewing radiographs, the most specific finding is an obliterated or very narrow pulp chamber and root canal. Bulbous crowns and cervical constriction are observed. Roots are often short and abnormally thin. In some patients, periapical radiolucency (periapical rarefaction) is seen, which is a sign of pulp infection.
Histologic findings: Globular or abnormal mineralization patterns of dentin, clustered large blood vessels in the pulp chamber, and irregular arrangement and reduction of dentinal tubules are observed. Dentin hardness is reduced to about 50–80% of normal.
Systemic signs of DGI-I: In affected patients, blue or gray-blue sclerae, recurrent fractures, short stature, spinal deformities, and joint hypermobility are additionally assessed. Hearing tests may show conductive or sensorineural hearing loss. When systemic findings are present, consultation with pediatrics or endocrinology is needed.
There is no systematic population screening program for dentinogenesis imperfecta. The main triggers for diagnosis are routine dental checkups or parents noticing their child's tooth discoloration and visiting a dentist.
Early dental visits and panoramic radiography: Regular dental visits are recommended from the time of primary tooth eruption (after 6 months of age); if tooth discoloration or abnormal wear is found during this period, panoramic radiography and evaluation by a dental specialist should follow. If pulp chamber obliteration or bulbous crowns are found on panoramic radiography, DGI is strongly suspected.
Family history: Check whether parents or siblings have a history of tooth discoloration, excessive wear, or early tooth loss. If the family history is positive, actively consider the possibility of DGI and plan early dental treatment. Because inheritance is autosomal dominant, children of an affected parent need monitoring from eruption onward.
Suspected OI (DGI-I): When dental abnormalities are accompanied by findings such as recurrent fractures, small build relative to height, and blue sclerae, OI-related tests (skeletal survey radiography, COL1A1/COL1A2 gene analysis, biochemical markers) are performed together.
Genetic testing: When clinical and radiographic findings are consistent with DGI and there is a family history, DSPP gene analysis (NGS-based or targeted variant analysis) is performed for molecular confirmation. Before genetic counseling, the clinical significance and limitations of genetic testing are fully explained.
Diagnosis of dentinogenesis imperfecta is made by an integrated approach of clinical findings, radiographic findings, family history, and genetic testing when needed.
Clinical diagnostic criteria: Clinical diagnosis is possible when ① amber or blue-gray tooth discoloration, ② enamel cracking and wear, ③ bulbous crowns with cervical constriction, ④ family history (autosomal dominant), and ⑤ radiographic findings (pulp chamber obliteration, short roots) are present. According to the Shields classification, DGI-I and DGI-II are distinguished by the presence or absence of OI.
Radiographic diagnosis: On panoramic or bitewing radiographs, bulbous crowns, cervical constriction, early obliteration or narrowing of the pulp chamber, and short, thin roots are typical findings of DGI. In DGI-III, the pulp chamber may instead be widely open. Periapical radiolucency can be observed even in non-infected teeth, but infection should be assessed clinically.
Differential diagnosis: Amelogenesis imperfecta (AI), in which the main finding is an enamel abnormality, needs to be clinically distinguished from DGI. In AI, the enamel itself is thin or defective, whereas in DGI, the abnormality of the underlying dentin causes enamel loss. Radiographic findings help with differentiation. Dental fluorosis is distinguished by history of fluoride exposure and radiographic findings.
Genetic confirmation: Confirmation is made by identifying a pathogenic variant on DSPP gene testing (sequencing, exome analysis, or a rare dental disease panel). When DGI-I is suspected, COL1A1/COL1A2 gene analysis and OI-related clinical tests are performed together. Genetic confirmation is also essential for prognostic counseling, family testing, and preimplantation or prenatal genetic diagnosis.
The goal of treatment for dentinogenesis imperfecta is to preserve dental function (mastication, esthetics, pain prevention) and minimize tooth loss. The treatment plan is individualized according to age, extent of dental involvement, and patient compliance.
Treatment of primary teeth: Early preventive treatment begins when the primary teeth erupt. The most effective method is full coverage with stainless steel crowns (SSC) to prevent wear and fracture. SSCs are applied to primary molars and premolars, and composite resin or polycarbonate crowns are used for anterior teeth. Early restorative treatment of primary teeth is important to maintain space for eruption of permanent teeth and to preserve occlusal function.
Treatment of permanent teeth: DGI is often milder in permanent teeth than in primary teeth, but active treatment is still needed. Mild to moderate: composite resin restoration (restoration of cervical defects), application of fissure sealant. Moderate to severe: ceramic or metal-ceramic full coverage crowns covering the entire occlusal, buccal, and lingual surfaces. Crown restoration is performed while maintaining the occlusal vertical dimension (OVD), preserving as much natural tooth structure as possible. Because root canal treatment is technically very difficult when the pulp chamber is obliterated, preventive protection with crowns before pulp exposure is recommended.
Implants and removable dentures: When multiple teeth are lost, osseointegrated implants are considered, but in DGI-I (with OI) patients, implant failure rates may be high because of low bone mass and density. Implant procedures are considered in adults who have completed growth, and in patients with OI, careful assessment of the jawbone must come first. In children and adolescents before completion of growth, function is maintained with partial or complete removable dentures (removable prosthesis).
Systemic treatment of DGI-I (with OI): Systemic treatment of OI (intravenous bisphosphonates such as pamidronate and zoledronic acid) reduces fracture frequency and improves bone density. There is no systemic drug therapy for DGI itself. Collaboration by a multidisciplinary team (pediatrics, orthopedics, dentistry, medical genetics, rehabilitation medicine) is needed for optimal outcomes in OI-DGI patients.
The prognosis of dentinogenesis imperfecta depends greatly on whether active dental treatment is started early. Without treatment, severe loss of dentition can occur, but with systematic dental care, most patients can maintain a functional dentition over the long term.
Prognosis of primary teeth: Protecting primary teeth early with full stainless steel crowns maintains function and space until eruption of the permanent teeth. Without treatment, rapid wear and fracture reduce tooth height, leading to occlusal dysfunction, speech problems, and reduced lower facial height.
Prognosis of permanent teeth: The permanent teeth of DGI patients are often relatively less severely affected than the primary teeth, but without treatment wear and sensory hypersensitivity progress. With timely full crown restoration, a functional dentition can be maintained for decades or longer. When the pulp chamber is obliterated, root canal treatment for pulp infection is very difficult or impossible and may lead to tooth extraction, so preventive coverage is key.
Systemic prognosis of DGI-I (with OI): Systemic prognosis depends on OI severity. Bisphosphonate treatment reduces fracture frequency, but the long-term complications of OI itself (vertebral compression fractures, hearing loss, decreased pulmonary function, etc.) affect quality of life.
Psychosocial impact: Severe tooth discoloration and wear can negatively affect the self-esteem, peer relationships, and school life of children and adolescents. Psychological support may be needed along with early esthetic and functional dental treatment. In adults, improving tooth appearance with esthetic treatment (porcelain crowns, veneers, etc.) improves quality of life.
The only specific way to prevent the occurrence of dentinogenesis imperfecta itself is intervention at the genetic level. However, active preventive dental treatment after diagnosis can minimize complications (wear, fracture, infection, tooth loss).
Genetic counseling and preimplantation genetic diagnosis: An affected parent passes DGI to each child with a 50% probability. Reproductive options (natural pregnancy followed by prenatal diagnosis, preimplantation selection via PGT-M, adoption, etc.) are fully discussed through genetic counseling. When a DSPP variant has been identified, selective implantation of unaffected embryos is possible through PGT-M.
Early dental treatment and preventive restoration: In affected children, follow-up by a dental specialist should begin from the time of primary tooth eruption. Preventive coverage with stainless steel crowns or composite resin before enamel cracking begins can prevent dentin exposure and rapid wear. Regular 6-monthly dental checkups and radiographic follow-up detect new lesions early.
Mouthguard use: When nocturnal bruxism is present, a soft mouthguard is worn to minimize occlusal wear. Wearing a sports mouthguard during sports activities reduces the risk of tooth fracture.
Oral hygiene: Dentin exposed by tooth wear may be more vulnerable to caries (cavities). Caries prevention is strengthened with topical fluoride (fluoride varnish), antibacterial mouthwash, and thorough toothbrushing education. Intake of acidic foods and drinks is limited to minimize dental erosion.
Systemic management of patients with OI: In DGI-I (with OI) patients, systemic preventive measures such as bisphosphonate treatment for fracture prevention, physical therapy, and use of orthoses should be carried out at the same time.
Shields ED, Bixler D, el-Kafrawy AM. A proposed classification for heritable human dentine defects with a description of a new entity. Arch Oral Biol. 1973;18(4):543-553. DOI: 10.1016/0003-9969(73)90075-1. PMID: 4514098.
Xiao S, Yu C, Chou X, et al. Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet. 2001;27(2):201-204. DOI: 10.1038/84853. PMID: 11175791.
Zhang X, Zhao J, Li C, et al. DSPP mutation in dentinogenesis imperfecta Shields type II. Nat Genet. 2001;27(2):151-152. DOI: 10.1038/84765. PMID: 11175782.
Lindau B, Dietz W, Hoyer I, Lundgren T, Storhaug K, Noren JG. Discrimination of DI types II and III by variations in intertubular dentin composition and thickness of peritubular dentin. Eur J Oral Sci. 1999;107(3):179-189. DOI: 10.1046/j.0909-8836.1999.eos107305.x. PMID: 10424376.
MacDougall M, Simmons D, Luan X, Nydegger J, Feng J, Gu TT. Dentin phosphoprotein and dentin sialoprotein are cleavage products expressed from a single transcript coded by the gene DSPP. J Biol Chem. 1997;272(2):835-842. DOI: 10.1074/jbc.272.2.835. PMID: 8995372.
Kim JW, Simmer JP. Hereditary dentin defects. J Dent Res. 2007;86(5):392-399. DOI: 10.1177/154405910708600502. PMID: 17452562.
Malmgren B, Lindskog S. Assessment of dysplastic dentin in osteogenesis imperfecta and dentinogenesis imperfecta. Acta Odontol Scand. 2003;61(2):72-80. DOI: 10.1080/00016350310001073. PMID: 12790502.
Hartsfield JK Jr. Pharmacogenetics and pharmacogenomics in pediatric dentistry: current status and future considerations. Pediatr Dent. 2010;32(2):110-122. PMID: 20483017.
Porntaveetus T, Ohazama A, Choi SK, et al. Expression of novel secreted frizzled-related proteins (Sfrps) in the dental mesenchyme. Cell Tissue Res. 2011;344(2):285-292. DOI: 10.1007/s00441-011-1155-0. PMID: 21437619.
de La Dure-Molla M, Philippe Fournier B, Berdal A. Isolated dentinogenesis imperfecta and dentin dysplasia: revision of the classification. Eur J Hum Genet. 2015;23(4):445-451. DOI: 10.1038/ejhg.2014.159. PMID: 25138099.